鞣花酸
脊髓
药理学
脊髓损伤
炎症
医学
血脑屏障
微泡
间充质干细胞
中枢神经系统
氧化应激
抗氧化剂
骨髓
脐带血
化学
药物输送
免疫系统
细胞毒性
免疫学
干细胞
程序性细胞死亡
麻醉
作者
Xiaoling Zhou,Yan Lin,Rongqiu Wang,Yanling WU,Xingyue Zhong,Jili Wu,Zaiyi Luo,Fei Lei,Xingyuan Liu,Xiyao Li,Xueyun Xu,Yanqi Li,Lanlan Yang,Changguang Wang,Zhirong Zhong,Zhongbing Liu,Youkun Zheng,Xiaoduan Sun,Zhirong Zhong
摘要
Following primary mechanical trauma, spinal cord injury evolves through a complex secondary cascade involving blood-spinal cord barrier disruption, ischemia-reperfusion injury, oxidative stress, and neuroinflammation, which collectively propagate neuronal death, demyelination, and glial scarring to preclude functional recovery. Current treatments mitigate single processes but not all at once, limiting their efficacy. To develop an effective multivalent treatment, the small molecule ellagic acid, which inhibits inflammation and oxidative damage while protecting the barrier between blood and spinal cord, was encapsulated within exosomes derived from bone marrow mesenchymal stem cells. These exosomes, by themselves, have been shown to promote neural repair, and loading ellagic acid into them stabilized the drug and increased its bioavailability. The ellagic acid-loaded exosomes (Exos-EA) were formulated into a self-healing chitosan/hyaluronic acid hydrogel (Exos-EA@CS/HA-Gel) to prolong their retention and release at the injection site. The resulting Exos-EA@CS/HA-Gel inhibited lipopolysaccharide-induced inflammatory responses in murine microglial cultures and protected human neuroblastoma cell lines from death due to oxidative stress. In a rat model of spinal cord injury, Exos-EA@CS/HA-Gel restored the function of the barrier between blood and spinal cord, promoting tissue repair. These results suggest that Exos-EA@CS/HA-Gel may be effective against spinal cord injury.
科研通智能强力驱动
Strongly Powered by AbleSci AI